A Polymorphism in ABCC4 Is Related to Efficacy of 5-Fu/Capecitabine-Based Chemotherapy in Colorectal Cancer Patients

Scientific Reports - United Kingdom
doi 10.1038/s41598-017-07491-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Thymidylate Synthase Gene Polymorphism Predicts Toxicity in Colorectal Cancer Patients Receiving 5-Fluorouracil-Based Chemotherapy

Clinical Cancer Research
Cancer ResearchOncology
2004English

miR-329 Regulates the Sensitivity of 5-Fu in Chemotherapy of Colorectal Cancer by Targeting E2F1

Oncology Letters
Cancer ResearchOncology
2018English

Predictive Value of TLR7 Polymorphism for Cetuximab-Based Chemotherapy in Patients With Metastatic Colorectal Cancer

International Journal of Cancer
Cancer ResearchOncology
2017English

A Study of Capecitabine Metronomic Chemotherapy Is Non-Inferior to Conventional Chemotherapy as Maintenance Strategy in Responders After Induction Therapy in Metastatic Colorectal Cancer

Trials
MedicinePharmacology
2020English

Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer

Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
2011English

The Role of GLI1 for 5-Fu Resistance in Colorectal Cancer

Cell and Bioscience
BiochemistryGeneticsMolecular Biology
2017English

PML as a Potential Predictive Factor of Oxaliplatin/Fluoropyrimidine-Based First Line Chemotherapy Efficacy in Colorectal Cancer Patients

Journal of Cellular Physiology
Clinical BiochemistryCell BiologyPhysiology
2011English

Role of Capecitabine in Treating Metastatic Colorectal Cancer in Chinese Patients

OncoTargets and Therapy
OncologyPharmacology
2014English

GOLPH3 Predicts Survival of Colorectal Cancer Patients Treated With 5-Fluorouracil-Based Adjuvant Chemotherapy

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy